OUR COMPANY

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

The technology perfected by X’Prochem is used for the chemical synthesis of long, complex peptides and proteins.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

This flexible and scalable approach allows for the design and manufacturing of a new generation of biologics.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

The technology also offers a cost-effective way to produce biosimilar drugs.

OUR TECHNOLOGY

Our technology is extremely accurate, efficient, and scalable under GMP conditions

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Complex proteins can be produced:

As single entities

With precisely located substitutions or side-chains

And the correct folding

Multiple properly paired disulfide bridges can also be engineered.

Opening new avenues

New generations of biologic medicines can now be designed and manufactured.

A large variety of specific, precisely controlled modifications can be reliably engineered and produced under GMP

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

PEGylation, phosphorylation, glycosylation, acylation etc.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Unnatural amino acids

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Fusion proteins

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Cyclic protein

OUR OFFER

We aim to become a major driver and partner in the development of new, complex biologics as well as competitive bio-generics.

We help address a wide range of R&D interests,
from short-term “problem solving” projects to long-term development and production partnerships.

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Customer driven

Tailor-made “protein tools” to support the development of drug candidates

Production of proteins not feasible by recombinant approaches

De novo synthesis of unnatural sequences

Custom-modifications to optimize drug leads

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Biosimilar

Synthesis of existing or future off-patent biologics

Cost effective GMP production

xprochem, x prochem, protein, proteins, biologic, biologics, protein biologics, technology, chemical synthesis, long peptides, long proteins, complex peptides, complex proteins, new generation of biologics, innovation in biologics, cost-effective way, biosimilar drugs, precision, innovation in biologic medicines, new generation of biologic medicines, competitive bio-generics, R&D, reseaarch and development, customer driven, biosimilar, quality standars, protein tools, de novo synthesis, unatural sequences, optimization of drug leads, gmp production, certificate of analysis, ligation technology, scientific and business expertise, PEGylation, phosphorylation, glycosylation, acylation, Unnatural amino acids, Fusion proteins, Cyclic protein

Quality standards

Certificate of analysis (identity, purity …) provided with all compounds

Ad hoc release tests as needed

The management team combines scientific and business expertise

Reda Mhidia, PhD

Founder – Chief Executive Officer

PhD in Medicinal chemistry

MBA in innovation management

Julien Dheur, PhD

Founder – Chief Science Officer

PhD in Organic chemistry

Author of numerous papers, patents and book chapters on proteins and peptides chemistry

Denis Henrard

COO

Brings +20 years of global business management and development  experience, notably at J&J and Abbott Laboratories in the US

Philippe Grit

Head of Sales

Brings +20 years of successful commercial experience in the pharmaceutical industry

Contact us

Address

1, rue du Professeur Calmette
59021 Lille Cedex - FRANCE

Email

contact@xprochem.com

Call us

+33 641 97 71 59
Top